View More Recent Stories
-
Raymond James Downgrades Danaher (DHR) to Market Perform
-
Danaher (DHR) PT Lowered to $260 at TD Cowen as 'Weak Guide Spoils 4Q'
-
Danaher (DHR) PT Lowered to $260 at Stifel
-
Danaher (DHR) PT Lowered to $277 at RBC Capital, Reflecting Lowered FY'25/26 Estimates
-
Danaher (DHR) call put ratio 1.9 calls to 1 put with a focus on February 235 and 245 calls as share price down 9%
-
Danaher (DHR) PT Lowered to $265 at BofA Securities
-
Danaher (DHR) Misses Q4 EPS by 1c, offers guidance
-
Danaher (DHR) call put ratio 1.4 calls to 1 put into quarter results
-
Danaher (DHR) call put ratio 1.2 calls to 1 put into quarter results
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Danaher (DHR) call put ratio 1 call to 2.2 puts with a focus on January 235 puts
-
Waters Corp. (WAT), Others Decline on Concerns about New Export Controls on Biotech Equipment
-
Danaher (DHR) CEO to Comment on Financial Performance
-
Guggenheim Starts Danaher (DHR) at Buy
-
Wolfe Research Upgrades Danaher (DHR) to Outperform
-
Wolfe Research Upgrades Danaher (DHR) to Outperform
-
Danaher (DHR) PT Raised to $310 at KeyBanc
-
Danaher (DHR) PT Raised to $315 at TD Cowen
-
Danaher (DHR) PT Lowered to $277 at Baird
-
Danaher (DHR) PT Lowered to $275 at Leerink Partners
-
Danaher (DHR) Tops Q3 EPS by 14c; offers outlook
-
Danaher (DHR) October 25 weekly call option implied volatility into quarter results
-
Danaher (DHR) call put ratio 1.4 calls to 1 put into quarter results
-
Danaher (DHR) call put ratio 4.9 calls to 1 put with focus on December 280 calls into quarter results
-
TD Cowen Reiterates Buy Rating on Danaher (DHR)
-
Danaher (DHR) Confirms Third Quarter and Full Year 2024 Guidance
-
Danaher (DHR) PT Raised to $310 at TD Cowen
-
Danaher (DHR) PT Raised to $300 at Argus
-
Danaher (DHR) PT Raised to $250 at Stifel
-
Danaher (DHR) PT Raised to $275 at BofA Securities
-
Danaher (DHR) PT Raised to $275 at Evercore ISI
-
Midday movers: Coca-Cola, Spotify rise; UPS, Comcast fall
-
Danaher (DHR) Tops Q2 EPS by 15c; offers outlook
-
Danaher (DHR) July 26 weekly option implied volatility into quarter results
-
Danaher (DHR) July weekly 245 straddle priced into quarter results
-
10 policies if Trump wins and stock implications: Jefferies
-
Danaher (DHR) July 240 and 245 puts active
-
Danaher (DHR) Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development
-
Life Science Tools & Diagnostics stocks: Q2 earnings preview
-
Danaher (DHR) Announces Resignation of EVP Joakim Weidemanis
-
Danaher (DHR) July puts active as share price down 4.3%

